One of the greatest challenges of the 21st century encountered by the health care sector is neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease – so called protein misfolding…
Read More
Minimizing harm to patients from inadequately-tested new pharmaceuticals — and the bankroll-boggling process of adequate testing — are grabbing pandemic headlines. “The pharmaceutical industry needs new ways of doing things”…
Although scaling up for mass production remains an ongoing challenge in the world of microfluidics, other developments are driving positive predictions. For example, the microfluidic immunoassay market recently welcomed a…
When commercializing a microfluidic technology, you start with a contraption put together from wires, tubing, pumps, power supplies, and microscopes, and you turn it into an instrument other labs can…
Microfluidic technology is based on devices capable of handling micro to picolitre amounts of samples, and their applications are diverse ranging from pharmaceuticals, healthcare to the chemical industry. As this…
Names carry weight. The names of prestigious institutions and prolific scientists offer credibility. So to do scientific (and pseudoscientific) monikers: “double-blind clinical trials” assure integrity through rigour, and “superfoods” assure…
Rising demand for point-of-care testing The rising prevalence of lifestyle-related & infectious diseases and an increasing preference for self-testing are driving the global point-of-care diagnostics market. In addition, growing private…
For over three decades, a revolutionary impact of microfluidic technology on science and industrial applications has been envisioned; however, such predictions have not been met regardless of a large number…
